Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamid Emamekhoo

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|August 9, 2023
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter AnalysisKevin Hakimi, Ava Saidian, Justine Panian, et al.
Molecular Oncology|February 19, 2021
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA TrialChung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
The Oncologist|June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following ImmunotherapyJustine Panian, Ava Saidian, Kevin Hakimi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2022
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew Bootsma, Rana R McKay, Hamid Emamekhoo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyTimothy Gilligan, Daniel W Lin, Rahul Aggarwal, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2025
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline UpdateRohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.
European Urology Oncology|December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study DataTanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|August 9, 2023
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter AnalysisKevin Hakimi, Ava Saidian, Justine Panian, et al.
Molecular Oncology|February 19, 2021
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA TrialChung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
The Oncologist|June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following ImmunotherapyJustine Panian, Ava Saidian, Kevin Hakimi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2022
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew Bootsma, Rana R McKay, Hamid Emamekhoo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyTimothy Gilligan, Daniel W Lin, Rahul Aggarwal, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2025
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline UpdateRohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.
European Urology Oncology|December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study DataTanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
Pageof 7